Literature DB >> 389787

In vitro investigation of autoantibody-secreting peritoneal cells and their regulation.

K O Cox, D Evans, D Brooks, D A Cunliffe.   

Abstract

A high proportion of peritoneal cells from untreated mice, after 4--5 days in culture, develop into plaque-forming cells against bromelain-treated mouse red blood cells. The number of plaque-forming cells was increased significantly by exposing the peritoneal cells to ammonium chloride to lyse red blood cells before culture. Conversely, the increase was significantly inhibited by adding before culture untreated or bromelain-treated sheep or mouse red blood cells. Treated or untreated horse or rat red blood cells did not inhibit the increase. Treating peritoneal cells or subpopulations of peritoneal cells with anti-theta serum and complement before culture caused a significant increase in the number of plaque-forming cells against bromelain-treated red blood cells after 3--4 days of culture. Various procedures were used to fractionate peritoneal cells into B-cell enriched and B-cell depleted subpopulations before culture and after culture, to investigate whether some of the plaque-forming cells could be attributed to phagocytic cells. Generally, changes in the number of plaque-forming cells against bromelain-treated mouse red blood cells paralleled changes in B-cells. In some experiments the proportion of plaque-forming cells observed represented up to 85% of the B-cells present. The results suggest that the high level of autoreactivity is due to antibody production by B-cells and that phagocytic cells are not forming spurious plaques. Further, it appears that the autoimmunity is regulated by T-cells and can also be inhibited by mouse RBC.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389787      PMCID: PMC1457941     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Establishment and characterization of a permanent murine hybridoma secreting monoclonal autoantibodies.

Authors:  J M Pages; A E Bussard
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

2.  T-cell mediated immunity towards antigen(s) on isologous erythrocytes.

Authors:  I A Ramshaw; D Eidinger
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

3.  Most IgM-producing cells in the mouse secrete auto-antibodies (rheumatoid factor).

Authors:  D W Dresser
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

4.  Ontogeny of the antibody-forming cell line in mice. IV. Appearance of cells bearing Fc receptors, complement receptors, and surface immunoglobulin.

Authors:  Y J Rosenberg; C R Parish
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  High proportion of Ig-producing cells making autoantibody in normal mice.

Authors:  E J Steele; A J Cunningham
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

6.  Evaluation of the effect of ammonium chloride treatment on the activity of human effector cells in antibody-dependent and spontaneous cell-mediated cytotoxicity.

Authors:  D Santoli; G Trinchieri
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

7.  Precommitment of normal mouse peritoneal cells by erythrocyte antigens in relation to auto-antibody production.

Authors:  J Pages; A E Bussard
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

8.  The properties of plaque-forming cells from autoimmune and normal strains of mice with specificity for autologous erythrocyte antigens.

Authors:  E M Lord; R W Dutton
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  Antibody formation in nonimmune mouse peritoneal cells after incubation in gum containing antigen.

Authors:  A E Bussard
Journal:  Science       Date:  1966-08-19       Impact factor: 47.728

10.  Studies of the antigenicity and immunogenicity of bromelain-pretreated red blood cells.

Authors:  K O Cox; H Baddams; A Evans
Journal:  Aust J Exp Biol Med Sci       Date:  1977-02
View more
  7 in total

1.  Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

Authors:  A C Crawley; D A Brooks; V J Muller; B A Petersen; E L Isaac; J Bielicki; B M King; C D Boulter; A J Moore; N L Fazzalari; D S Anson; S Byers; J J Hopwood
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

2.  Mitogenic effects of glycolipoprotein extract from Pseudomonas aeruginosa.

Authors:  A M Varey; A Cooke; G Dimitrocopoulos; M Papamichail
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

3.  Multiple organ-reactivity of monoclonal autoantibodies to mouse erythrocytes.

Authors:  C Garzelli; F Basolo; C Puglisi; A Pacciardi
Journal:  Experientia       Date:  1987-08-15

4.  Autoantibodies against mouse bromelain-modified RBC are specifically inhibited by a common membrane phospholipid, phosphatidylcholine.

Authors:  K O Cox; S J Hardy
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

5.  Evidence for autoantibody production associated with polyclonal B-cell activation by Pseudomonas aeruginosa.

Authors:  C Garzelli; M Campa; V Colizzi; G Benedettini; G Falcone
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  T cells or their products are required for the differentiation of precursor B cells into antibody-secreting cells specific for a supposed T-independent self-antigen.

Authors:  S Daenke; K O Cox
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

7.  Immunological defects in SJL mice.

Authors:  P R Hutchings; A M Varey; A Cooke
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.